As per Barclays, the US administration announced numerous executive orders with reforms associated with world trade, immigration, and global geopolitics, resulting in elevated...
Keep Reading →
April 8 - Hedge Funds, News
On Thursday, April 3rd, the host of Mad Money opened the most recent show by addressing the growing concerns surrounding the current tariff policies.
Keep Reading →
April 7 - Hedge Funds, News
Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA to treat or prevent diseases.
Keep Reading →
March 31 - Hedge Funds, News
Jim Cramer, the host of Mad Money, offered an optimistic perspective on the market on Thursday as he challenged the prevailing pessimism among some on Wall Street.
Keep Reading →
March 30 - Hedge Funds, News
After being in the green for a few trading sessions, the broader market index slid 0.8% on Wednesday, and blue-chip companies declined 0.1%.
Keep Reading →
March 26 - Insider Trading, News
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer reiterated that the Trump administration has to clarify its narrative about tariffs to convince the average American...
Keep Reading →
March 19 - News
After two years of 25%+ gains, some investors worry that stocks are overvalued.
Keep Reading →
March 15 - Hedge Funds, News
Although biotech stocks had a "challenging" year in 2024, JPMorgan believes that some of the industry's companies could see significant growth in the months to come.
Keep Reading →
March 15 - Hedge Funds, News
The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income countries.
Keep Reading →
March 14 - Hedge Funds, News
The US pharmaceutical sector is experiencing a distinct trend never seen before with large American pharma companies continually looking for medicines in China.
Keep Reading →
March 11 - Hedge Funds, Industries, News
The American quant hedge fund Renaissance Technologies is known for using statistical and mathematical tools to drive its investment programs.
Keep Reading →
February 22 - Hedge Funds, News
Jim Cramer, the host of Mad Money, has been considering the uncertainty surrounding 2025 and the ongoing macroeconomic challenges that are sparking important questions.
Keep Reading →
January 30 - Hedge Funds, News
Healthcare has been one of Jim Cramer's favorite topics lately.
Keep Reading →
December 31 - News
In his second appearance on Squawk on the Street after the Fed's interest rate cut, Jim Cramer had a lot to say about the Fed's decision and the Personal Consumption Expenditure...
Keep Reading →
December 24 - News
Jurrien Timmer, Director of Global Macro at Fidelity Management & Research Company, recently shared his outlook for the stock market in 2025.
Keep Reading →
December 24 - Hedge Funds, News
The Federal Reserve created quite a bit of turmoil in the stock market on Wednesday when despite cutting interest rates, it signaled to investors that the journey to low rates...
Keep Reading →
December 23 - News
Jim Cramer, host of Mad Money, recently reflected on how investors often overlook obvious opportunities, particularly with cult stocks, which in hindsight appear to be clear success...
Keep Reading →
December 18 - Hedge Funds, News
With the 2024 US Presidential Election having come to a close, Wall Street can now focus on the future of artificial intelligence, the Federal Reserve's interest rate cut cycle...
Keep Reading →
November 20 - News
Renaissance Technologies is an American hedge fund that specializes in systematic trading and employs statistical and mathematical tools to drive its investment programs.
Keep Reading →
October 6 - Hedge Funds, News
As we have mentioned in our article, “10 Best Penny Stocks to Buy Under $1," the size of the global biotechnology industry was assessed to be worth $1.38 trillion in 2023 and...
Keep Reading →
September 5 - Industries, News
In this article, we are going to discuss the 10 best healthcare stocks to buy according to hedge funds.
Keep Reading →
June 24 - Hedge Funds, News
We recently published a list Analyst Recommends 10 Best Stocks to Diversify Your Portfolio Away from Mega-Cap Tech and AI Stocks. Since Vertex Pharmaceuticals Incorporated (NASDAQ...
Keep Reading →
June 19 - Hedge Funds, News
Venu Krishna, Head of U.S.
Keep Reading →
June 18 - Hedge Funds, News
With the passage of time, the role of women in the modern day workplace has slowly started to grow.
Keep Reading →
June 14 - Hedge Funds, News
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is the leading...
Keep Reading →
June 3 - Hedge Funds
In this article, we will be discussing the best gene therapy stocks to buy now. Before we move on to our list, let's take a look at the market outlook for gene therapies and ...
Keep Reading →
June 3 - Hedge Funds, News, Stock Analysis
In this article, we will discuss the 10 stocks whose price targets were recently raised by analysts.
Keep Reading →
May 8 - Market Movers, News
In this article, we discuss the 23 most profitable stocks of the last 12 months.
Keep Reading →
May 4 - Hedge Funds, News
In this article, we will be taking a look at the 5 biggest biotechnology companies in the world.
Keep Reading →
March 17 - News
In this article, we will take a look at the 5 biotech stocks with huge potential.
Keep Reading →
March 8 - Hedge Funds, News
In this article, we will be taking a look at the 20 fastest growing biotech companies in the US.
Keep Reading →
February 23 - Lists, News
In this piece, we will take a look at the 14 best medical stocks to invest in according to hedge funds.
Keep Reading →
February 17 - Hedge Funds, News
In this article, we discuss the top 5 CRISPR stocks to invest in.
Keep Reading →
February 10 - News
In this article, we will take a look at the 30 most valuable drug companies in 2024.
Keep Reading →
February 10 - Business, Industries, Lists, News
The United States economy has continued to defy expectations of a macro slowdown over the past few months and looks set to grow at a healthy pace in the first quarter of 2024.
Keep Reading →
January 22 - Hedge Funds, News
In this piece, we will take a look at the five most promising gene editing stocks according to hedge funds.
Keep Reading →
December 20 - Hedge Funds, News
In this article, we will be taking a look at the 30 largest pharmaceutical companies in the world.
Keep Reading →
December 12 - Industries, Lists, News
In this article, we discuss Jim Simons and his top 10 stock picks.
Keep Reading →
December 8 - Hedge Funds, News
Incyte Corporation (NASDAQ:INCY) is a biopharmaceutical company that engages in the discovery, development, and commercialization of therapeutics for hematology and oncology.
Keep Reading →
November 16 - Hedge Funds, News
In this piece, we will take a look at the five biggest healthcare stocks in Jim Simons' stock portfolio.
Keep Reading →
November 13 - Hedge Funds, News
In this piece, we will take a look at the 12 best low beta stocks to buy.
Keep Reading →
November 13 - Hedge Funds, News
In this article, we will be taking a look at the top 20 drug companies in the US by revenue.
Keep Reading →
November 9 - Industries, Lists, News
In this piece, we will take a look at five cheap biotechnology stocks that smart investors are piling into.
Keep Reading →
October 20 - Hedge Funds
In this article, we discuss 5 DNA stocks that billionaires love.
Keep Reading →
June 14 - Hedge Funds, News
In this article, we take a look at 27 largest biotech companies in the US.
Keep Reading →
April 29 - Lists, News
In this article, we will take a look at the 5 gene editing stocks with the best long-term potential.
Keep Reading →
April 26 - Hedge Funds, News
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) and its affiliated companies specialize in creating a platform for cell programming.
Keep Reading →
April 20 - Hedge Funds, News
The healthcare sector in 2022 outperformed the market despite several headwinds and a negative macroeconomic backdrop.
Keep Reading →
January 21 - Hedge Funds, News
Below we take a look at Jim Simons Stock Portfolio: 5 Biggest Healthcare Stocks.
Keep Reading →
December 31 - Hedge Funds, News
In this article, we discuss the 5 biotech stocks with the biggest upside.
Keep Reading →
December 13 - Hedge Funds, News